An Act to protect 340B providers in the Medicaid program
By Mr. Crighton, a petition (accompanied by bill, Senate, No. 845) of Brendan P. Crighton for legislation to not restrict or limit an eligible hospital’s access to the discounted purchase of prescription drugs in the Medicaid program. Health Care Financing.
This legislation amends the section of MGL governing restriction on the ability of hospitals to purchase discounted drugs under section 340B of the Public Health Service Act. It adds new language specifying that the secretary may not take actions that restrict the coverage of drugs purchased by MassHealth recipients, unless the drug costs more than $100,000 per patient per year, or is one of seven GLP-1 Agonist drugs that is restricted from reimbursement under federal law. Intended to ensure that 340B drugs are not denied to MassHealth members on account of cost.
The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.